Mark Ruffalo

Showing 9726 articles
Business

Quest Diagnostics: A Value Play in Healthcare After Strong Run?

Shares of Quest Diagnostics (DGX) have delivered robust returns over multiple timeframes, prompting investors to question if the rally has room to run. A deep dive into valuation metrics suggests the stock may still be trading at a discount to its intrinsic value, even after recent gains.

Business

Fiserv's Deep Dive: Is a 72% Plunge a Buying Opportunity or a Value Trap?

After a brutal year that saw Fiserv shares lose nearly three-quarters of their value, investors are grappling with a critical question: Is this a moment of profound mispricing or a justified reflection of fundamental challenges? A deep dive into valuation models suggests a significant gap between price and perceived intrinsic value.